XML 70 R59.htm IDEA: XBRL DOCUMENT v3.23.1
INTANGIBLE ASSETS AND GOODWILL - Narrative (Details)
2 Months Ended 3 Months Ended 12 Months Ended
Oct. 01, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
reporting_unit
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Goodwill [Line Items]                    
Asset impairments       $ 13,000,000       $ 8,000,000    
Finite-lived intangible assets       3,854,000,000 $ 4,102,000,000       $ 4,102,000,000  
Goodwill impairment                 824,000,000  
Goodwill       11,579,000,000 11,547,000,000       11,547,000,000 $ 12,457,000,000
Accumulated goodwill impairment charges       5,004,000,000            
Bausch + Lomb                    
Goodwill [Line Items]                    
Number of reporting units | reporting_unit     3              
Salix                    
Goodwill [Line Items]                    
Goodwill impairment                 0  
Goodwill       3,159,000,000 $ 3,159,000,000       $ 3,159,000,000 $ 3,159,000,000
Dermatology Reporting Unit                    
Goodwill [Line Items]                    
Reporting unit, impairment test, long-term growth rate   1.00% 1.00%     1.00% 1.00% 1.00%    
Reporting unit, impairment test, estimated cash flows, discount rate   10.50% 10.00%     10.50% 10.00% 9.00%    
Fair value of reporting value, greater than its carrying value               2.00%    
Goodwill impairment           $ 119,000,000 $ 83,000,000 $ 0    
Reporting unit, impairment test, estimated cash flows, change in discount rate     1.00%       1.00%      
Goodwill   $ 480,000,000       $ 480,000,000        
Vision Care, Surgical and Ophthalmic Reporting Units | Bausch + Lomb                    
Goodwill [Line Items]                    
Fair value of reporting value, greater than its carrying value     25.00%   25.00%   25.00%   25.00%  
Goodwill impairment     $ 0   $ 0          
Salix Reporting Unit                    
Goodwill [Line Items]                    
Reporting unit, impairment test, long-term growth rate   2.50%       2.50%        
Fair value of reporting value, greater than its carrying value   5.00%       5.00%        
Goodwill impairment           $ 0        
Neurology and Other Reporting Unit                    
Goodwill [Line Items]                    
Reporting unit, impairment test, long-term growth rate         (2.50%)       (2.50%)  
Reporting unit, impairment test, estimated cash flows, discount rate         10.25%       10.25%  
Goodwill impairment $ 622,000,000                  
Goodwill         $ 1,439,000,000       $ 1,439,000,000  
Minimum | Vision Care, Surgical and Ophthalmic Reporting Units | Bausch + Lomb                    
Goodwill [Line Items]                    
Reporting unit, impairment test, long-term growth rate     2.00%   2.00%   2.00%   2.00%  
Reporting unit, impairment test, estimated cash flows, discount rate     9.00%   9.50%   9.00%   9.50%  
Minimum | Salix Reporting Unit                    
Goodwill [Line Items]                    
Reporting unit, impairment test, estimated cash flows, discount rate   9.75%       9.75%        
Maximum | Vision Care, Surgical and Ophthalmic Reporting Units | Bausch + Lomb                    
Goodwill [Line Items]                    
Reporting unit, impairment test, long-term growth rate     3.00%   3.00%   3.00%   3.00%  
Reporting unit, impairment test, estimated cash flows, discount rate     11.50%   12.25%   11.50%   12.25%  
Maximum | Salix Reporting Unit                    
Goodwill [Line Items]                    
Reporting unit, impairment test, estimated cash flows, discount rate   10.00%       10.00%        
Xifaxan Branded Products                    
Goodwill [Line Items]                    
Impairment of intangible assets   $ 0   0            
Finite-lived intangible assets       $ 2,559,000,000            
Finite lived intangible assets, useful life       57 months            
Xifaxan Branded Products | Salix | Revenue from Contract with Customer, Segment Benchmark | Product Concentration Risk                    
Goodwill [Line Items]                    
Concentration risk percentage       80.00%       80.00%    
Trade Names No Longer Used                    
Goodwill [Line Items]                    
Impairment of intangible assets       $ 8,000,000            
Discontinued Product Lines                    
Goodwill [Line Items]                    
Impairment of intangible assets       $ 5,000,000       $ 8,000,000